Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial of Special Issue "Molecular Research and Recent Advances in Diabetic Retinopathy: Second Edition".

Biomedicines·2026
Same author

Potential of R Wave in aVL Lead in Cardiovascular Risk Assessment.

Biomedicines·2026
Same author

Incidence of Ventricular Arrhythmias and Sudden Cardiac Death with Cardiac Myosin Inhibitors in Hypertrophic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.

Journal of personalized medicine·2026
Same author

Diagnostic Accuracy and Real-Life Advantages of the MONA.health Artificial Intelligence Software in Screening for Diabetic Retinopathy and Maculopathy.

Diagnostics (Basel, Switzerland)·2026
Same author

Transcutaneous Carbon Dioxide Therapy Significantly Accelerates Diabetic Foot Ulcer Healing: A Multicentre Randomised Controlled Trial.

Biomedicines·2026
Same author

Special Issue: "Recent Advances in Hypertension, Hypercholesterolemia and Type 2 Diabetes".

Biomedicines·2026

Related Experiment Videos

Mediterranean Dietary Pattern in Type 2 Diabetes Management: Pathways and Clinical Evidence.

Dubravka Majić Milotić1, Tomislav Bulum1,2, Kristijan Peroš1

  • 1Department of Diabetes and Endocrinology, Vuk Vrhovac University Clinic for Diabetes, Endocrinology and Metabolic Diseases, Merkur University Hospital, 10000 Zagreb, Croatia.

Biomedicines
|June 26, 2026
PubMed
Summary

The Mediterranean diet (MedDiet) improves type 2 diabetes mellitus (T2DM) management by enhancing glycemic control and insulin sensitivity. This dietary pattern offers metabolic benefits and complements medications for T2DM prevention and treatment.

Keywords:
Mediterranean diethealthy fatsomega-3 fatty acidsplant-based foodstype 2 diabetes

Related Experiment Videos

Area of Science:

  • Nutritional Science
  • Endocrinology
  • Metabolic Health

Background:

  • Type 2 diabetes mellitus (T2DM) is a growing global health concern.
  • Dietary interventions are crucial for T2DM prevention and management.
  • The Mediterranean diet (MedDiet) shows promise for metabolic health.

Purpose of the Study:

  • To synthesize the biological pathways of the MedDiet.
  • To link MedDiet mechanisms with clinical evidence for T2DM.
  • To review MedDiet's role in T2DM prevention and management.

Main Methods:

  • Narrative review of existing literature.
  • Analysis of molecular mechanisms and clinical outcomes.
  • Integration of MedDiet's effects on inflammation, metabolism, and gut microbiota.

Main Results:

  • MedDiet adherence improves glycemic control and insulin sensitivity.
  • Mechanisms include anti-inflammatory effects, improved amino acid metabolism, and enhanced gut microbiota function.
  • MedDiet complements T2DM medications like GLP-1 receptor agonists and SGLT-2 inhibitors.

Conclusions:

  • The MedDiet is a valuable strategy for T2DM prevention and management.
  • It offers benefits in glycemic control, weight management, and cardiovascular risk reduction.
  • MedDiet's multifaceted approach supports overall metabolic health in T2DM.